Xu, 2000 - Google Patents
Characterization of WISP-1 as a Wnt-1 and β-catenin-regulated oncogeneXu, 2000
- Document ID
- 12400611016794206539
- Author
- Xu L
- Publication year
External Links
Snippet
The Wnt signaling pathway is implicated in multiple human cancers. There is mounting evidence to suggest that uncontrolled activation of Wnt downstream genes directly contribute to tumor development. This dissertation research focuses on the identification of …
- 102000011777 Wnt1 Protein 0 title abstract description 54
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xu et al. | WISP-1 is a Wnt-1-and β-catenin-responsive oncogene | |
Harrison et al. | Drosophila unpaired encodes a secreted protein that activates the JAK signaling pathway | |
EP0991758B1 (en) | Smad6 and uses thereof | |
Stone et al. | Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli | |
Forsthoefel et al. | The Abelson tyrosine kinase, the Trio GEF and Enabled interact with the Netrin receptor Frazzled in Drosophila | |
Zhao et al. | Foxp1/2/4 regulate endochondral ossification as a suppresser complex | |
Andrew et al. | The Drosophila dCREB-A gene is required for dorsal/ventral patterning of the larval cuticle | |
KR100553300B1 (en) | Promotion or Inhibition of Angiogenesis and Cardiovascularization | |
US6605443B1 (en) | Method for identifying compounds that affect Smad7 binding | |
EP0972037A2 (en) | $g(b)-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER | |
Zhao et al. | Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2 | |
Van Ham et al. | Cloning and characterization of mCRIP2, a mouse LIM‐only protein that interacts with PDZ domain IV of PTP‐BL | |
Xu | Characterization of WISP-1 as a Wnt-1 and β-catenin-regulated oncogene | |
Wang et al. | Synleurin, a novel leucine-rich repeat protein that increases the intensity of pleiotropic cytokine responses | |
WO2000011195A9 (en) | C-myc is activated by beta-catenin and tcf-4 | |
WO1999050280A1 (en) | Compositions and methods for controlling brca1-mediated p53-dependent and -independent regulation of transcription | |
Barish et al. | 1. GENERAL OVERVIEW | |
Wang | Signaling mechanism and regulation of Frizzled | |
Jurata | Identification and analysis of the nuclear LIM domain interactor NLI | |
Yingling | Characterization of a novel TGF-beta signal transduction pathway | |
Zimmerman | Inhibition of Smad-mediated activin and TGFβ signaling by calmodulin | |
Muller et al. | Cell biology | |
Martinelli | The function of Gas1 in Hedgehog signaling | |
Liberati | Identification of Smad3-interacting proteins to reveal the role of Smads in TGFβ signaling and tumor suppression | |
Peschard | The role of Cbl-mediated ubiquitination in the regulation of the Met receptor tyrosine kinase |